| Secondary |
| Epilepsy |
21.1% |
| Product Used For Unknown Indication |
19.2% |
| Drug Use For Unknown Indication |
15.2% |
| Status Epilepticus |
7.7% |
| Convulsion |
6.6% |
| Sedation |
6.6% |
| Urinary Tract Infection |
5.6% |
| Polytraumatism |
2.6% |
| Parkinson's Disease |
2.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.6% |
| Escherichia Bacteraemia |
1.4% |
| Ill-defined Disorder |
1.4% |
| Multiple Myeloma |
1.4% |
| Essential Hypertension |
1.2% |
| Pulmonary Embolism |
1.2% |
| Sjogren's Syndrome |
1.2% |
| Antibiotic Therapy |
0.9% |
| Atrial Fibrillation |
0.9% |
| Bipolar I Disorder |
0.9% |
| Calcium Metabolism Disorder |
0.9% |
|
| Urinary Tract Infection |
11.8% |
| Septic Shock |
10.3% |
| Hyperlipasaemia |
8.8% |
| Treatment Noncompliance |
8.8% |
| Rash Maculo-papular |
4.4% |
| Rash Pustular |
4.4% |
| Renal Failure Acute |
4.4% |
| Self Injurious Behaviour |
4.4% |
| Sudden Death |
4.4% |
| Toxic Epidermal Necrolysis |
4.4% |
| Toxic Skin Eruption |
4.4% |
| Urticaria |
4.4% |
| Vision Blurred |
4.4% |
| Coma |
2.9% |
| Cytolytic Hepatitis |
2.9% |
| Dizziness |
2.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.9% |
| Fatigue |
2.9% |
| Nerve Injury |
2.9% |
| Overdose |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.6% |
| Epilepsy |
16.2% |
| Convulsion |
11.7% |
| Drug Use For Unknown Indication |
11.0% |
| Headache |
7.2% |
| Depression |
5.4% |
| Pain |
4.8% |
| Rheumatoid Arthritis |
2.8% |
| Prophylaxis |
2.7% |
| Hypertension |
2.5% |
| Bone Disorder |
2.2% |
| Osteoporosis |
1.9% |
| Lung Disorder |
1.6% |
| Petit Mal Epilepsy |
1.4% |
| Gastric Disorder |
1.3% |
| Non-small Cell Lung Cancer |
1.3% |
| Mineral Supplementation |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
| Rhinitis Allergic |
1.1% |
| Syncope |
1.1% |
|
| Weight Decreased |
15.7% |
| Vomiting |
9.4% |
| Weight Increased |
8.7% |
| Malnutrition |
7.1% |
| Somnolence |
6.3% |
| Epilepsy |
5.5% |
| Thrombocytopenia |
5.5% |
| Urinary Tract Infection |
5.5% |
| Petit Mal Epilepsy |
3.9% |
| Status Epilepticus |
3.9% |
| Fall |
3.1% |
| Hypokalaemia |
3.1% |
| Listless |
3.1% |
| Platelet Count Decreased |
3.1% |
| Thrombosis |
3.1% |
| Toxic Skin Eruption |
3.1% |
| Convulsion |
2.4% |
| Fatigue |
2.4% |
| Hepatic Failure |
2.4% |
| Hyponatraemia |
2.4% |
|
| Interacting |
| Convulsion |
32.1% |
| Nervousness |
21.4% |
| Breast Cancer |
14.3% |
| Epilepsy |
7.1% |
| Hallucination |
7.1% |
| Pulmonary Embolism |
7.1% |
| Acne |
3.6% |
| Sleep Disorder |
3.6% |
| Tonsillitis |
3.6% |
|
| Throat Tightness |
33.3% |
| Drug Interaction |
16.7% |
| Road Traffic Accident |
16.7% |
| Visual Impairment |
16.7% |
| Weight Increased |
16.7% |
|
